The tape-stripping technique as a method for drug quantification in skin

Journal of Pharmacy and Pharmaceutical Sciences

Volumn 11, Issue 1, 2008, Pages 104-130

  Escobar Chávez, Jose Juan ^a,b   Merino Sanjuan V ^a   Lopez Cervantes M ^b   Urban Morlan, Z ^b   Pinon Segundo E ^b   Quintanar Guerrero, D ^b   Ganem Quintanar, A ^b  

^a UNIVERSITY OF VALENCIA   (Spain)

^b UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

ADHESIVE AGENT; DIAGNOSTIC AGENT; DRUG;

ANIMAL; CHEMISTRY; DRUG EFFECT; EPIDERMIS; HUMAN; INTRADERMAL DRUG ADMINISTRATION; METABOLISM; PHYSIOLOGY; REVIEW; SKIN; SKIN ABSORPTION;

ADHESIVES; ADMINISTRATION, CUTANEOUS; ANIMALS; EPIDERMIS; HUMANS; PHARMACEUTICAL PREPARATIONS; SKIN; SKIN ABSORPTION;

EID: 53549096250     PISSN: None     EISSN: 14821826     Source Type: Journal    
DOI: 10.18433/J3201Z     Document Type: Article

References (118)

1. Bommannan D, Potts RO, Guy RH. Examination of stratum corneum barrier function in vivo by infrared spectroscopy. J Invest Dermatol 95: 403-408, (1990).
2. Higo N, Naik A, Bommannan DB, Potts RO, Guy R. H. Validation of reflectance infrared spectroscopy as a quantitative method to measure percutaneous absorption in vivo. Pharm Res.10:1500-1505, (1993).
3. Lotte C, Wester RC, Rougier A, Maibach HI. Racial differences in the in vivo percutaneous absorption of some organic compounds: a comparison between black, Caucasian and Asian subjects. Arch Dermatol Res. 284:456-459, (1993).
4. Pershing LK, Silver BS, Krueger GG, Shah VP, Skelley JP. Feasibility of measuring the bioavailability of topical betamethasone dipropionate in commercial formulations using drug content in skin and a skin blanching bioassay. Pharm Res. 9:45-51, (1992).
5. Rougier A, Dupuis D, Lotte C, Roguet R, Wester RC, Maibach HI. Regional variation in percutaneous absorption in man: measurement by the stripping method. Arch Dermatol Res. 278:465-469, (1986).
6. Tojo K, Lee AC. A method for prediction of steady-state of skin penetration in vivo. J Invest. Dermatol., 92:105-108, (1989).
7. Escobar-Chávez JJ, Quintanar-Guerrero D, and Ganem-Quintanar A. In vivo skin permeation of sodium naproxen formulated in PF-127 gels: Effect of Azone® and Transcutol®, Drug Develop Ind Pharm. 31:447-454, (2005).
8. Pinkus H. Examination of the epidermis by the strip method of removing horny layers. I. Observation on thickness of the horny layer, and on mitotic activity after stripping. J. Invest. Dermatol., 16:383-386, (1951).
9. King CS, Barton SP, Nicholls S, Marks R. The change in properties of the stratum corneum as a function of depth. Br J Dermatol., 100:165-172, (1979). Repetido 43
10. Shah VP. Topical Dermatological Drug Product NDAs and ANDAs-In Vivo Bioavailability, Bioequivalence, In Vitro Release and Associated Studies, US Department of Health and Human Services, Rockville, (1998).
11. Conner DP: Differences in DPK Methods. http://www.fda.gov/ohrms/dockets/ac/01/slides/3804s2_05_conner/index.htm, Advisory Committee for Pharmaceutical Sciences Meeting, Center for Drug Evaluation and Research (CDER), Food and Drug Administration (FDA), Rockville, Maryland, November 29, (2001).
12. Franz TJ. Study #1, Avita Gel 0.025% vs Retin-A Gel 0.025%, Advisory committee for pharmaceutical sciences meeting, Center for Drug Evaluation and Research (CDER), Food and Drug Administration (FDA), Rockville, Maryland, November 29, (2001).
13. Pershing LK. Bioequivalence assessment of three 0.025% tretinoin gel products: dermatopharmacokinetic vs clinical trial methods, advisory committee for pharmaceutical sciences meeting, Center for Drug Evaluation and Research (CDER), Food and Drug Administration (FDA), Rockville, Maryland, November 29, (2001).
14. Touitou E, Meidan VM, Horwitz E. Methods for quantitative determination of drug localized in the skin. J Control Rel. 56:7-21, (1998).
15. Moser K, Kriwet K, Naik A, Kalia YN, Guy R. H. Passive skin penetration enhancement and its quantification in vitro. Eur J Pharm Biopharm. 52:103-112, (2001).
16. Pinkus H. Tape stripping in dermatological research. A review with emphasis on epidermal biology. G Ital Dermatol Minerva Dermatol. 107(5):1115-26, (1966).
17. Forslind BA. Domain mosaic model of skin barrier. Acta Derm Venereol. 74:1-6, (1994).
18. Potts RO, Francoeur ML. The influence of stratum corneum morphology on water permeability. J Invest Dermatol. 96, 495-499, (1991).
19. Potts RO, Guy RH. Predicting skin permeability. Phar. Res, 9(5): 663-669, (1992).
20. Ellias PM. Epidermal barrier function: intercellular lamellar lipid structures, origin, composition and metabolism, J Control Rel. 15, 199-208, (1991).
21. Barry BW. Dermatological Formulations: Percutaneous Absorption. In: Swarbick J, ed. Drugs and the Pharmaceutical Sciences. New York and Basel: Marcel Dekker, Inc. p.202, (1983).
22. Hadgraft J. Skin, the final frontier. Int J Pharm. 224 (1-2):1-18, (2001).
23. Guy RH and Hadgraft J. Transdermal drug delivery. New York: Marcel Dekker, Inc., p. 1-23, (2003).
24. Walters KA and Roberts MS. Dermatological and transdermal formulations. New York: Marcel Dekker, Inc., p. 1-39, (2002).
25. Nevill AM. The need to scale for differences in body size and mass: and explanation of Kliebeŕs 0.75 mass exponent. Am Physiol Soc. 2870-2873, (1994).
26. Olvera-Martínez BI, Cazares-Delgadillo J, Calderilla-Fajardo SB, Villalobos-García R, Ganem-Quintanar A, Quintanar-Guerrero D. Preparation of polymeric nanocapsules containing octyl methoxycinnamate by the emulsification-diffusion technique: Penetration across the stratum corneum. J Pharm Sci. 94:1552-1559, (2005).
27. Escobar-Chávez JJ, López-Cervantes M, Naïk A, Kalia YN, Quintanar-Guerrero D, Ganemc Quintanar A. Applications of the thermoreversible Pluronic F-127 gels in pharmaceutical formulations, J Pharm Pharmaceut Sci. 9(3):339-358, (2006).
28. Miyazaki S, Yokouchi Ch, Nakamura T, Hashiguchi N, Hou W-M, and Takada M. Pluronic F-127 gels as a novel vehicle for rectal administration of indomethacin, Chem Pharm Bull.34, 1801-1808, (1986).
29. Chi SCh, Do K, Tan HK, and Chun HW. Antiinflammatory and analgesic transdermal gel, United States Patents., Patent number 5,527,832, (1996).
30. Fang JY, Leu YL, Wang YY, and Tsai YH. In vitro topical application and in vivob phramacodynamic evaluation of nonivamide hydrogels using Wistar rat as an animal model, Eur. J Pharm Sci. 15(5):417-423, (2002).
31. Shin SC, Cho CW, and Oh IJ. Effects of non ionic surfactants as permeation enhancers towards piroxicam from the poloxamer gel through rat skins, Int J Pharm. 222(2), 199-203, (2001).
32. Liaw J, and Lin Y-Ch. Evaluation of poly(ethylene oxide)-poly(propylene oxide)-poly(ethylene oxide) (PEO-PPO-PEO) gels as a release vehicle for percutaneous fentanyl, J Control. Rel. 68:273-282, (2000).
33. Wang YY, Hong CT, Chiu WT, and Fang JY. In vitro and in vivo evaluations of topically applied capsaicin and nonivamide from hydrogels, Int J Pharm. 224,1-2, (2001).
34. Kattan El, A. F., Asbill, C. S., Kim, N., and Michniak, B. B. Effect of formulation variables on the percutaneous permeation of ketoprofen from gel formulations, Drug Deliv. 7,3, (2000).
35. Curdy C, Kalia YN, Naïk A, Guy RH. Piroxicam delivery into human stratum corneum in vivo: iontophoresis versus passive diffusion. J Control Rel. 76, 73-79, (2001).
36. Mattorano DA, Kupper LL, Nylander-French LA. Estimating dermal exposure to jet fuel (naphthalene) using adhesive tape strip samples. Ann Occup Hyg. 48(2): 139-146, (2004).
37. Chao Y-Ch, Nylander-French LA. Determination of Keratin Protein in a Tapestripped Skin Sample from Jet Fuel Exposed Skin. Ann Occup Hyg. 48(1):65-73, (2004).
38. Tsai J-C, Weiner ND, Flynn GL, Ferry J. Properties of adhesive tapes used for stratum corneum stripping, Int J Pharm. 72: 227-231, (1991).
39. Sheth NV, McKeough MB, Spruance SL. Measurement of the stratum corneum drug reservoir to predict the therapeutic efficacy of topical iododeoxyuridine for herpes simplex virus infection. J Invest Dermatol. 89: 598-602, (1987).
40. Ohman H, Vahlquist A. In vivo studies concerning a pH gradient in human stratum corneum and upper epidermis. Acta Derm Venereol (Stockh). 74: 375-379, (1994).
41. Bashir, S. J., Chew, A. L., Anigbogu, A. Physical and physiological effects of stratum corneum tape stripping. Skin Res Technol. 7:40-48, (2001).
42. Marttin E, Neelissen-Subnel MTA, De Haan FHN, Boddé HE. A critical comparison of methods to quantify stratum corneum removed by tape-stripping. Skin Pharmacol. 9:69-77, (1996).
43. Löffler H, Dreher F, Maibach HI. Stratum corneum adhesive tape stripping: influence of anatomical site, application pressure, duration and removal. Br J Dermatol. 151: 746-752, (2004).
44. Van der Molen RG, Spies F, Van 't Noordende JM, Boelsma E, Mommaas AM, Koerten HK. Tape stripping of human stratum corneum yields cell layers that originate from various depths because of furrows in the skin. Arch Dermatol Res. 289:514-518, (1997).
45. Surber C, Schwarb FP, Fmith EW. Tape stripping technique. In: Percutaneous Absorption-Drug-Cosmetics-Mechanisms-Methodology (Bronough H, Maibach HI, eds), 3rd ed. New York: Marcel Dekker, 395-409, (1999).
46. Nangia A, Camel E, Berner B. Influence of skin irritants on percutaneous absorption. Pharm Res.10:1756-1759, (1993).
47. Van Voorst Vader PC, Lier JG, Woest TE. Patch tests with house dust mite antigens in atopic dermatitis patients: methodological problems. Acta Derm. Venereol (Stockh).,71:301-305, (1991).
48. Surakka J, Johnsson S, Rosen G. A method for measuring dermal exposure to multifunctional acrylates. J Environ Monit.1:533-540, (1999).
49. Kondo H, Ichikawa Y, Imokawa G. Percutaneous sensitization with allergens through barrier-disrupted skin elicits a Th2-dominant cytokine response. Eur J Immunol. 28: 769-779, (1998).
50. Fluhr JW, Gloor M, Lehmann L. Glycerol accelerates recovery of barrier function in vivo. Acta Derm Venereol (Stockh). 79:418-21, (1999).
51. Pechere M, Krischer J, Remondat C. Malassezia spp. Carriage in patients with seborrheic dermatitis. J Dermatol. 26:558-61, (1999).
52. Pechere M, Remondat C, Bertrand C. A simple quantitative culture of Malassezia spp. in HIVpositive persons. Dermatology.191:348-349, (1995).
53. Ghadially R, Brown BE, Sequeira-Martin SM. The aged epidermal permeability barrier. Structural, functional, and lipid biochemical abnormalities in humans and a senescent murine model. J Clin Invest.95:2281-90, (1995).
54. Van der Valk PG, Maibach HI. A functional study of the skin barrier to evaporative water loss by means of repeated cellophane-tape stripping. Clin Exp Dermatol.15:180-2, (1990).
55. Hostynek JJ, Dreher F, Pelosi A. Human stratum corneum penetration by nickel. In vivo study of depth distribution after occlusive application of the metal as powder. Acta Derm Venereol (Stockh).212 (Suppl.):5-10, (2001).
56. Lademann J, Otberg N, Richter H. Investigation of follicular penetration of topically applied substances. Skin Pharmacol Appl Skin Physiol. 14 (Suppl.1):17-22, (2001).
57. Wilhelm KP, Surber C, Maibach HI. Effect of sodium lauryl sulfate-induced skin irritation on in vivo percutaneous penetration of four drugs. J Invest Dermatol. 97:927-32, (1991).
58. Schafer U. Topical Absorption of Dermatological Products. Robert L. Bronaugh and Howard I. Maibach (Editors), Marcel Dekker, New York, Basel, 544 p, (2001).
59. Shah VP, Flynn GL, Yacobi A, Maibach HI, Bon C, Fleischer NM, Franz TJ, Kaplan SAJK, Lesko LJ, Marty JP, Pershing LK, Schaefer H, Sequeira JA, Shrivastava SP, Wilkin J, Williams RL. Bioequivalence of topical dermatological dosage forms-methods of evaluation of bioequivalence. Pharm Res. 15, 167-171, (1998).
60. Surakka J, Lindh T, Rosen G. Workers' dermal exposure to UV-curable acrylates in the furniture and parquet industry. Ann Occup Hyg. 44:635-44, (2000).
61. Nylander-French LA. A tape-stripping method for measuring dermal exposure to multifunctional acrylates. Ann Occup Hyg. 44:645-51, (2000).
62. Howes D, Guy R, Hadgraft J, Heylings J, Hoeck U, Kemper F, Maibach H, Marty JP, Merk H, Parra J, Rekkas D, Rondelli I, Schaefer H, Täuber U, Verbiese N. Methods for assessing percutaneous absorption. The report and recommendations of ECVAM workshop 13. ATLA 24, 81-106, (1996).
63. Arima H, Miyajib T, Irie T, Hirayama F, Uekamaa K. 1998. Enhancing effect of hydroxypropyl-P-cyclodextrin on cutaneous penetration and activation of ethyl 4-biphenylyl acetate in hairless mouse skin. Eur J Pharm Sci. 6:53-59, (1998).
64. Esposito E, Cortesi R, Drechsler M, Paccamiccio L, Mariani P, Contado C, Stellin E, Menegatti E, Bonina F, Puglia C. Cubosome dispersions as delivery systems for percutaneous administration of indomethacin. Pharm Res., 22(12):2163-2173, (2005).
65. Ganem-Quintanar A, Silva-Alvarez M, Alvarez-Roman R, Casas-Alancaster N, Cazares-Delgadillo J, Quintanar-Guerrero D. Design and evaluation of a self-adhesive naproxen-loaded film prepared from a nanoparticle dispersión. J Nanosci Nanotechnol. 6(9-10):3235-3241, (2006).
66. Herkenne C, Naik A, Kalia YN, Hadgraft J, Guy RH. Pig ear skin ex vivo as a model for in vivo dermatopharmacokinetic studies in man. Pharm Res. 23(8), 1850-1856, (2006).
67. Hostýnek JJ, Dreher F, Maibach HI. 2006. Human stratum corneum penetration by copper: In vivo study after occlusive and semiocclusive application of the metal as powder. Food Chem Toxicol. 44:1539-1543, (2006).
68. Lodén M, Akerstrom U, Lindahl K, Berne B. 2004. Bioequivalence determination of topical ketoprofen using a dermatopharmacokinetic approach and excised skin penetration. Int J Pharm. 284:23-30, (2004).
69. Wagner S and Merfort I. Skin penetration behaviour of sesquiterpene lactones from different Arnica preparations using a validated GC-MSD method. J Pharm Biomed Anal. In press, (2006).
70. Wagner H, Kostka K-H, Lehr C-M, Schaefer UF. Correlation between stratum corneum/water-partition coefficient and amounts of flufenamic acid penetrated into the stratum corneum. J Pharm Sci. 91(8):1915-1921, (2002).
71. Pellanda C, Ottiker E, Strub C, Figueiredo V, Rufli T, Imanidis G, Surber C. Topical bioavailability of triamcinolone acetonide: Effect of dose and application frequency. Arch Dermatol Res. 298:221-230, (2006).
72. Lboutounne H, Chaulet JF, Ploton C, Falson F, Pirot F. Sustained ex vivo skin antiseptic activity of chlorhexidine in poly(ecaprolactone) nanocapsule encapsulated form and as a digluconate. J Control Rel.82:319-334, (2002).
73. Fresno-Contreras MJ, Jiménez-Soriano MM, Ramírez-Diéguez A. In vitro percutaneous absorption of all-trans retinoic acid applied in free form or encapsulated in stratum corneum lipid liposomes. Int J Pharm. 297:134-145, (2005).
74. Padula C, Colombo G, Nicoli S, Catellani PL, Massimo G, Santi P. Bioadhesive film for the transdermal delivery of lidocaine: in vitro and in vivo behaviour. J Control Rel. 88: 277-285, (2003).
75. Bashir SJ, Dreher F, Chew AL, Zhai H, Levina C, Stern R, Maibach HI. 2005. Cutaneous bioassay of salicylic acid as a keratolytic. Int J Pharm. 292:187-194, (2005).
76. Abdulmajed K and Heard ChM. Topical delivery of retinyl ascorbate co-drug 1. Synthesis, penetration into and permeation across human skin. Int J Pharm. 280:113-124, (2004).
77. Hara M, Verkman AS. Glycerol replacement corrects defective skin hydration, elasticity, and barrier function in aquaporin-3-deficient mice. PNAS. 100(12):7360-7365, (2003).
78. Morgan CJ, Renwick AG, Friedmann PS. The role of stratum corneum and dermal microvascular perfusion in penetration and tissue levels of water-soluble drugs investigated by microdialysis. Br J Dermatol. 148:434-443, (2003).
79. Jarvis CA, McGuigan C, Heard CM. In vitro delivery of novel, highly potent anti-Varicella Zoster virus nucleoside analogues to their target site in the skin. Pharm Res. 21(6):914-919, (2004).
80. Strid J, Hourihane J, Kimber I, Callard R, Strobel S. Disruption of the stratum corneum allows potent epicutaneous immunization with protein antigens resulting in a dominant systemic Th2 response. Eur J Immunol.34:2100-9, (2004).
81. Inoue J, Yotsumoto S, Sakamoto T, Tsuchiya S, Aramaki Y. Changes in immune responses to antigen applied to tape-stripped skin with CpG oligodeoxynucleotide in mice. J Control Rel. 108:294-305, (2005).
82. Inoue, J. and Aramaki, Y. 2006. Toll-like receptor-9 expression induced by tape-stripping triggers on effective immune response with CpG-oligodeoxynucleotides. Vaccine. In press, (2006).
83. Ayala-bravo HA, Quintanar-Guerrero D, Naik A, Kalia YN, Cornejo-Bravo JM, Ganem-Quintanar A. 2003. Effects of sucrose oleate and sucrose laureate on in vivo human stratum corneum permeability. Pharm Res.20 (8):1267-1273, (2003).
84. Reddy MB, Stinchcomb AL, Guy RH, Bunge AL. Determining dermal absorption parameters in vivo from tape strip data. Pharm. Res., 19(3):292-298, (2002).
85. Jakasa I, Calkoen F, Kezic S. Determination of polyethylene glycols of different molecular weight in the stratum corneum. J Chromatogr B. 811:177-182, (2004).
86. Jakasa I, Verbek MM, Esposito M, Bos JD, Kezic S. Altered penetration of polyethylene glycols into uninvolved skin of atopic dermatitis patients. J Investigative Dermatol. 127:129-134, (2007).
87. Tsai J-C, Shen L-C, Sheu HM, Lu C-C. Tape stripping and sodium dodecyl sulfate treatment increase the molecular weight cut-off of polyethylene glycol penetration across murine skin. Arch Dermatol Res. 295:169-174, (2003).
88. Alvarez-Román R, Naik A, Kalia YN, Guy RH, Fessi H. Enhancement of topical delivery from biodegradable nanoparticles. Pharm Res. 21(10):1818-1825, (2004).
89. Sarveiya V, Risk S, Benson HAE. Liquid chromatographic assay for common sunscreen agents: application to in vivo assessment of skin penetration and systemic absorption in human volunteers. J Chromatogr B. 803:225-231, (2004).
90. Lademann J, Schanzer S, Richter H, Pelchrzim RV, Zastroe L, Golz K, Sterry W. Sunscreen application at the beach. J Cosmet Dermatol.3(2):62-68, (2004).
91. Mavon A, Miguel C, Lejeune O, Payre B, Moretto P. In vitro percutaneous absorption and in vivo stratum corneum distribution of an organic and mineral sunscreen. Skin Pharmacol Physiol. 20(1):10-20, (2007).
92. Brian KR, Green DM, Lalko J, Api AM. Invitro human skin penetration of the fragrance material geranyl nitrile. Toxicology in Vitro 21:133-138, (2007).
93. Teichmann A, Jacobi U, Waibler E, Sterry W, Lademann J. An in vivo model to evaluate the efficacy of barrier creams on the level of skin penetration of chemicals. Contact Dermatitis. 54:5-13, (2006).
94. Jacobi U, Tassopoulos T, Surber C, Lademann J. Cutaneous distribution and localization of dyes affected by vehicles all with different lipophilicity. Arch Dermatol Res. 297:303-310, (2006).
95. Van der Merwe D, Brooks JD, Gehring R, Baynes RE, Monteiro-Riviere NA, Riviere JE. A physiologically based pharmacokinetic model of organophosphate dermal absorption. Toxicol Sci. 89(1):188-204, (2006).
96. De Jongh CM, Jakasa I, Verberk MM, Kezic S. Variation in barrier impairment and inflammation of human skin as determined by sodium lauryl sulphate penetration rate. Br J Dermatol. 154:651-657, (2006).
97. Lundgren L, Skare L, Lidén C. Measuring dust on skin with a small vacuuming sampler-A comparison with other sampling techniques. Ann Occup Hyg.50(1):95-103, (2006).
98. Leveque JL, Corcuff P, de Rigal J, Agache, P. In vivo studies of the evolution of physical properties of the human skin with age. Int J Dermatol. 23:322-329, (1984).
99. Denda M, Koyama J, Hori J, Horii I, Takahashi M, Hara M, Tagami H. Age-and sex-dependent change in stratum corneum sphingolipids. Arch Dermatol Res. 285:415-417, (1993).
100. Somerville DA. The normal flora of the skin in different age groups. Br J Dermatol. 81:248-258, (1980).
101. Schurer NY, Plewig G, Elias PM. Stratum corneum lipid function. Dermatologica. 183:77-94, (1991).
102. Cua AB, Wilhelm KP, Maibach HI. Skin surface lipid and skin friction: Relation to age, sex and anatomical region. Skin Pharmacol. 8:246-251, (1995).
103. Marples RR. Sex, constancy, and skin bacteria. Arch Dermatol Res. 272: 317-320, (1982).
104. Fluhr JW, Dickel H, Kuss O, Weyher I, Diepgen TL, Berardesca E. Impact of anatomical location on barrier recovery, surface pH and stratum corneum hydration after acute barrier disruption. Br J Dermatol. 146: 770-776, (2002).
105. Jacobi U, Gautier J, Sterry W, Lademann J. Gender-Related Differences in the Physiology of the Stratum Corneum. Dermatology. 211:312-317, (2005).
106. Fatouros DG, Groeninka HWM, De Graaff AM, Van Aelst AC, Koertenc HK, Bouwstra JA. Visualization studies of human skin in vitro/in vivo under the influence of an electrical field. Eur J Pharm Sci.29:160-170, (2006).
107. Weerheim A. Ponec M. Determination of stratum corneum lipid profile by tape stripping in combination with high-performance thinlayer chromatography. Arch Dermatol Res.293:191-199, (2001).
108. Alberti, I., Kalia, Y. N., Naik, A., Bonny, J. D., & Guy, R. H. In vivo assessment of enhanced topical delivery of terbinafine to human stratum corneum. J Control Rel. 71(3), 319-327, (2001).
109. Kalia, Y. N., Pirot, F., & Guy, R. H. Homogeneous transport in a heterogeneous membrane: water diffusion across human stratum corneum in vivo. Biophys J. 71(5), 2692-2700, (1996).
110. Alouf JE, Muller-Alouf H. Staphylococcal and streptococcal superantigens: molecular, biological and clinical aspects. Int J Med Microbiol.292:429-440, (2003).
111. George A, Rubin G. A systematic review and meta-analysis of treatments for impetigo. Br J Gen Pract. 53:480-487, (2003).
112. Kugelberg E, Norström T, Petersen TK, Duvold T, Andersson DI, Hughes D. Establishment of a superficial skin infection model in mice by using Staphylococcus aureus and Streptococcus pyogenes. Antimicrob Agents Chem.49(8):3435-3441, (2005).
113. Forslund O, Lindelöf B, Hradil E, Nordin-Stenquist B, Kirnbauer R, Slupetzky K, Dillner J. High prevalence of cutaneous human papillomavirus DNA on the top of skin tumors but not in "Stripped" biopsies from the same tumors. J Invest Dermatol.123:388-394, (2004).
114. Malmminen M, Koivukangas V, Peltonen J, Karvonen S-L, Oikarinen A, Peltonen S. Immunohistological distribution of the tight junction components ZO-1 and occludin in regenerating human epidermis. Br J Dermatol. 149:255-260, (2003).
115. Sekkat N, Kalia YN, Guy RH. Biophysical study of porcine ear skin in vitro and its comparison to human skin in vivo. J Pharm Sci. 91(11):2376-2381, (2002).
116. Zhai H, Poblete N, and Maibach HI. Stripped skin model to predict irritation potential of topical agents in vivo in humans. Int J Dermatol, 37(5), 386-389, (1998).
117. th edition. CRC Press, Boca Raton, 327-337, (2008).
118. th edition. CRC Press, Boca Raton, 339-342, (2008).